Josh Craig, a trainee in our Personal Injury team, takes a look at recent research which suggests there may be a causal link between brain injury and homelessness – two issues of great importance to our entire firm.
As the festive season approaches, awareness of the risks of drink driving come to the forefront of our minds, not least due to an increase in adverts highlighting how, if we drink and drive, we may end up arrested, injured or possibly even dead. Fortunately, the majority of us do think twice about how we intend to travel home after meeting friends or loved ones for a drink or two.
Louise Hart, partner in our Personal Injury team and expert in limb loss claims, takes a look at a couple of inspiring organisations making prosthetics easier to access for kids who live with limb loss across the world.
As a specialist in representing individuals suffering from mesothelioma, lung cancer and asbestos-related diseases, I was invited to give a speech at Mesothelioma UK’s patient and carer day on 4 October on medicinal cannabis.
Here, Oliver Lewis – an Assistive Technology Consultant from Lewis Support – explains what assistive technology is and how suitable solutions and products are identified. He has also included examples of how assistive technology can support individuals who have experienced a mild traumatic brain injury (mTBI).
Recent news that a man may regain the full use of his hand after severing most of it in an accident demonstrates how amazing modern medicine can be, but what happens when fingers can’t be re-attached?
Incident reports are intended to establish the causes and contributory factors of a death or other avoidable event. For this reason they are very important, and something that should be taken very seriously by the trust or organisation completing them.
With today’s announcement that the discount rate will change to minus 0.25%, we give you a quick explainer as to what it is and what the change means for claimants.
Jennifer Seavor, Senior Associate and specialist mesothelioma claims solicitor, looks at the Diffuse Mesothelioma Payment Scheme (DMPS) which was introduced in 2014 and asks whether after four years more needs to be done.